Replies to post #11268 on Synaptogenix Inc (SNPX)

[Investor2014]

On the evidence that the market cap for a supposedly 98.8% chance of multiples in return remains at some $90m.

[SF Wolf]

Excellant point Whatsupp. It is not small investors who have been responsable for the recent price appreaciation in NTRP stock:

MYDA Advisors LLC Takes $690,000 Position in Neurotrope Inc (NTRP)
Posted by Kelly Messenger on Jun 7th, 2019

MYDA Advisors LLC acquired a new stake in Neurotrope Inc (NASDAQ:NTRP) in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 126,685 shares of the company’s stock, valued at approximately $690,000. MYDA Advisors LLC owned 0.98% of Neurotrope at the end of the most recent reporting period.

Other institutional investors also recently added to or reduced their stakes in the company. BlackRock Inc. lifted its position in shares of Neurotrope by 17.9% in the 1st quarter. BlackRock Inc. now owns 24,577 shares of the company’s stock worth $134,000 after purchasing an additional 3,729 shares during the period. Raymond James & Associates purchased a new stake in shares of Neurotrope in the 4th quarter worth approximately $42,000. Renaissance Technologies LLC lifted its position in shares of Neurotrope by 72.4% in the 3rd quarter. Renaissance Technologies LLC now owns 50,000 shares of the company’s stock worth $441,000 after purchasing an additional 21,000 shares during the period. Finally, Eaton Vance Management purchased a new stake in shares of Neurotrope in the 4th quarter worth approximately $164,000. 13.87% of the stock is owned by institutional investors.